Xin Zhang

Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells.

J. Smaill, Liang Chen, A. Patterson, 2022, Journal of medicinal chemistry.

Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia.

Zhe-Sheng Chen, Dong-Hua Yang, K. Ding, 2019, Cancer letters.

Design and synthesis of selective degraders of EGFRL858R/T790M mutant.

Lin-jiang Tong, Xiaoyun Lu, Hua Xie, 2020, European journal of medicinal chemistry.